Our results emphasise the importance of concurrent changes occurring to normal nuclear TDP-43 prior to aggregation, and novel interactions with diverse pathological assemblies that may drive TDP-43-related neurodegeneration in ALS and FTD. The gene discussed is TARDBP; the disease is amyotrophic lateral sclerosis.